Cornucopian Capital

Archon Bio is a biotechnology company that specializes in engineering proteins to enhance therapeutic outcomes. It focuses on creating self-assembling protein antibody nanomaterials, aiming to improve immune modulation and super agonism of the TNF receptor superfamily. By increasing the size and valency of off-the-shelf antibodies, Archon seeks to induce stronger responses, thereby advancing regenerative medicine and cancer treatment.

Ilant Health is a healthcare provider specializing in obesity management and cardiometabolic healthcare services. The company focuses on delivering effective obesity treatment through innovative analytics powered by unstructured machine learning. This approach has yielded significant insights into reducing total healthcare costs and enhancing return on investment for obesity treatment. By prioritizing value-based care, Ilant Health enables its clients to achieve better health outcomes while also managing costs more effectively.

InsideTracker is a personalized health analytics company founded by experts from MIT, Harvard, and Tufts University. The company offers a platform that analyzes key biochemical and physiological markers to provide users with insights into their health. By utilizing advanced algorithms and extensive scientific databases, InsideTracker identifies optimal ranges for these markers and generates customized recommendations for lifestyle and nutrition interventions. This approach empowers individuals to manage their health proactively, with a focus on enhancing vitality, improving performance, and potentially extending life. The platform synthesizes complex scientific findings into actionable insights, enabling users to make informed decisions about their well-being and optimize their overall health.